Chapter 29
Instrumentation and Technique
Irreversible Electroporation
Chad R. Tracy,
Jeffrey A. Cadeddu,
Chad R. Tracy
University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Search for more papers by this authorJeffrey A. Cadeddu
The University of Texas Southwestern Medical Center, Dallas, TX, USA
Search for more papers by this authorChad R. Tracy,
Jeffrey A. Cadeddu,
Chad R. Tracy
University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Search for more papers by this authorJeffrey A. Cadeddu
The University of Texas Southwestern Medical Center, Dallas, TX, USA
Search for more papers by this authorBook Editor(s):Manoj Monga MD, FACS,
Abhay Rane MS, FRCS(Urol),
Manoj Monga MD, FACS
Director
Stevan B. Streem Center for Endourology and Stone Disease, Glickman Urological and Kidney Institute, Cleveland Clinic Cleveland, OH, USA
Search for more papers by this authorAbhay Rane MS, FRCS(Urol)
Professor of Urology
East Surrey Hospital, Redhill, UK
Search for more papers by this authorFirst published: 25 October 2013
Summary
Current thermal ablation technologies, while successful in the management of renal cell carcinoma, are limited in terms of the types of tumors they can be used to treat. Irreversible electroporation is a nonthermal tissue ablation technology that has been shown to ablate normal cells while maintaining extracellular matrix. These differences in technology appear to open the door to ablation of more centralized tumors where there is concern for ineffective treatment due to heatsink or urothelial injury.
References
- Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and review. J Urol 2008; 179(4): 1227–33; discussion 1233–4.
- Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180(2): 499–504.
- Stein RJ, Kaouk JH. Renal cryotherapy: a detailed review including a 5-year follow-up. BJU Int 2007; 99(5 Pt B): 1265–70.
- Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116(13): 3135–42.
- Chang I, Mikityansky I, Wray-Cahen D, Pritchard WF, Karanian JW, Wood BJ. Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology 2004; 231(2): 500–5.
- Kariya Z, Yamakado K, Nakatuka A, Onoda M, Kobayasi S, Takeda K. Radiofrequency ablation with and without balloon occlusion of the renal artery: an experimental study in porcine kidneys. J Vasc Intervent Radiol 2003; 14(2 Pt 1): 241–5.
- Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. Am J Roentgenol 2002; 178(1): 47–51.
- Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Intervent Radiol 2003; 14(10): 1267–74.
- Best SL, Park SK, Yaacoub RF, et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol 2012; 187(4): 1183–9.
- Yoon SK, Choi JC, Cho JH, et al. Radiofrequency ablation of renal VX2 tumors with and without renal artery occlusion in a rabbit model: feasibility, therapeutic efficacy, and safety. Cardiovasc Intervent Radiol 2009; 32(6): 1241–6.
- Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. Am J Roentgenol 2005; 185(1): 72–80.
- Johnson DB, Saboorian MH, Duchene DA, Ogan K, Cadeddu JA. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology 2003; 62(2): 351–2.
- Brown DB, Bhayani SB. Persistent urine leak after cryoablation of a renal tumor in a patient with an ileal conduit. J Vasc Intervent Radiol 2007; 18(10): 1324–7.
- Margulis V, Matsumoto ED, Taylor G, Shaffer S, Kabbani W, Cadeddu JA. Retrograde renal cooling during radio frequency ablation to protect from renal collecting system injury. J Urol 2005; 174(1): 350–2.
- Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1982; 1(7): 841–5.
- Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality – clinical implications. Technol Cancer Res Treatment 2007; 6(1): 37–48.
- Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006; 53(7): 1409–15.
- Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33(2): 223–31.
- Deodhar A, Monette S, Single GW Jr, et al. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 2011; 77(3): 754–60.
- Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treatment 2005; 4(6): 699–705.
- Tracy CR, Kabbani W, Cadeddu JA. Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 2011; 107(12): 1982–7.
- Wendler JJ, Pech M, Porsch M, et al. Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Intervent Radiol 2012; 35(4): 921–6.
- Duffy BG, Anderson JK. Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol 2010; 26(3): 410–17.
- Olweny EO, Cadeddu JA. Novel methods for renal tissue ablation. Curr Opin Urol 2012; 22(5): 379–84.
- Pech M, Janitzky A, Wendler JJ, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011; 34(1): 132–8.
- Al-Khadra A, Nikolski V, Efimov IR. The role of electroporation in defibrillation. Circ Res 2000; 87(9): 797–804.
- Deodhar A, Dickfeld T, Single GW, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. Am J Roentgenol 2011; 196(3): W330–5.
- Nikolski VP, Efimov IR. Electroporation of the heart. Europace 2005; 7(suppl 2): 146–54.
- Tovar O, Tung L. Electroporation of cardiac cell membranes with monophasic or biphasic rectangular pulses. Pacing Clin Electrophysiol 1991; 14(11 Pt 2): 1887–92.
- Mali B, Jarm T, Corovic S, et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46(8): 745–57.
- CR Tracy, J Cadeddu (eds). Complications of Ablative Renal Procedures. Philadelphia: Springer Science + Business Media, 2010.
- CR Tracy, J Cadeddu (eds). Radiofrequency Ablation. Philadelphia: Springer, 2010.
